COX-2 inhibitors
- 1 January 1999
- journal article
- new drug-classes
- Published by Elsevier in The Lancet
- Vol. 353 (9149) , 307-314
- https://doi.org/10.1016/s0140-6736(98)12154-2
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Investigation of the Binding of Isoform-Selective Inhibitors to Prostaglandin Endoperoxide Synthases Using Fluorescence SpectroscopyBiochemistry, 1998
- Efficacy and Tolerability of Meloxicam versus Piroxicam in Patients with Osteoarthritis of the Hip or KneeClinical Drug Investigation, 1997
- Disruption of Cyclooxygenase Genes in MiceToxicologic Pathology, 1996
- Safety of Meloxicam: A Global Analysis of Clinical TrialsRheumatology, 1996
- A 4-Week, Double-Blind, Parallel-Group Study to Compare the Gastrointestinal Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20 mg and Placebo by Means of Faecal Blood Loss, Endoscopy and Symptom Evaluation in Healthy VolunteersRheumatology, 1996
- Meloxicam in Osteoarthritis: A 6-Month, Double-Blind Comparison with Diclofenac SodiumRheumatology, 1996
- A Double-Blind Study to Compare the Efficacy and Safety of Meloxicam 15 mg with Piroxicam 20 mg in Patients with Osteoarthritis of the HIPRheumatology, 1996
- A Six-Month Double-Blind Trial to Compare the Efficacy and Safety of Meloxicam 7.5 mg Daily and Naproxen 750 mg Daily in Patients with Rheumatoid ArthritisRheumatology, 1996
- MeloxicamDrugs, 1996
- NimesulideDrugs, 1994